Showing results (21-30 of 1,842) with videos related to
Sort By:
Pageof 185
Antimicrobial Agents and Chemotherapy|January 1, 1982
Clinical efficacy of cefotaxime in serious infectionsP H Karakusis, J M Feczko, L J Goodman, et al.Diagnostic Microbiology and Infectious Disease|May 1, 1989
In vitro activity of minocycline and rifampin against staphylococciJ Segreti, L C Gvazdinskas, G M TrenholmeDiagnostic Microbiology and Infectious Disease|August 1, 1993
In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficileJ Segreti, L J Goodman, G M TrenholmeThe Journal of Infectious Diseases|October 1, 1991
Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coliD M Simon, G Koenig, G M TrenholmeClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 1998
Prolonged suppressive antibiotic therapy for infected orthopedic prosthesesJ Segreti, J A Nelson, G M TrenholmeDiagnostic Microbiology and Infectious Disease|May 1, 1992
In vitro activity of beta-lactam drugs and sulbactam against Chlamydia trachomatisJ Segreti, K S Kapell, G M TrenholmeDiagnostic Microbiology and Infectious Disease|August 1, 1995
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus speciesM K Hayden, M G Matushek, G M TrenholmeThe American Journal of Medicine|August 9, 1985
Use of ceftazidime in the treatment of nosocomial lower respiratory infectionsG M Trenholme, J C Pottage, P H KarakusisAntimicrobial Agents and Chemotherapy|June 1, 1994
Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinationsM K Hayden, G I Koenig, G M TrenholmePageof 185